Document is current
Any future updates will be listed below
-
Authors
Rebordosa, Cristina https://orcid.org/0000-0002-8064-5997
Houben, Eline https://orcid.org/0000-0002-9173-3335
Laugesen, Kristina https://orcid.org/0000-0001-7971-8223
Bothner, Ulrich https://orcid.org/0000-0001-6515-0841
Montonen, Jukka https://orcid.org/0000-0002-4366-9439
Aguado, Jaume https://orcid.org/0000-0002-9575-0212
Overbeek, Jetty A. https://orcid.org/0000-0003-0935-5193
Ehrenstein, Vera https://orcid.org/0000-0002-3415-3254
Asmar, Joelle
Wallace, Laura https://orcid.org/0000-0002-6304-6036
Gilsenan, Alicia W. https://orcid.org/0000-0002-9266-1417
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
- License Information
-
More Information
Article History
Received: 7 August 2019
Accepted: 23 December 2019
First Online: 17 January 2020
Competing interests
: Cristina Rebordosa, Jaume Aguado, and Alicia Gilsenan are employees of RTI Health Solutions, a unit of RTI International, a non-profit organization that conducts work for government, public, and private organizations, including pharmaceutical companies like Boehringer Ingelheim. Eline Houben and Jetty Overbeek are employees of the PHARMO Institute for Drug Outcomes Research. This independent research institute performs financially supported studies for government and related health care authorities and several pharmaceutical companies. Joelle Asmar is employee of IQVIA, an independent research institute that performs financially supported studies for health care authorities and several pharmaceutical companies. Vera Ehrenstein and Kristina Laugesen are salaried employees of Aarhus University/Aarhus University Hospital. Ulrich Bothner, Jukka Montonen and Laura Wallace are employees of Boehringer Ingelheim.
